Stock Taper 
CATALIO CAPITAL MANAGEMENT, LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Ascendis Pharma A/S | ASND | 31.76K | $8.47M |
 Dianthus Therapeutics, Inc. | DNTH | 32.94K | $3.21M |
 Axsome Therapeutics, Inc. | AXSM | 43.18K | $10.57M |
 Veradermics, Incorporated | MANE | 45.86K | $5.64M |
 Natera, Inc. | NTRA | 82.18K | $22.31M |
 Protagonist Therapeutics, Inc. | PTGX | 106.8K | $13.09M |
 Outset Medical, Inc. | OM | 118.28K | $510.96K |
 Edwards Lifesciences Corporation | EW | 124.78K | $11.29M |
 Johnson & Johnson | JNJ | 138.95K | $35.29M |
 Immunocore Holdings plc | IMCR | 148.04K | $4.7M |
 Disc Medicine, Inc. | IRON | 159.38K | $11.66M |
 Incyte Corporation | INCY | 191.63K | $21.72M |
 Atai Beckley Inc. | ATAI | 196.86K | $1.04M |
 Dyne Therapeutics, Inc. | DYN | 244.93K | $5.44M |
 Gilead Sciences, Inc. | GILD | 269.31K | $34.02M |
 Kardigan, Inc. | KARD | 312.5K | $7.45M |
 Ultragenyx Pharmaceutical Inc. | RARE | 316.25K | $10.56M |
 Bristol-Myers Squibb Company | BMY | 412.96K | $23.79M |
 BridgeBio Pharma, Inc. | BBIO | 455.04K | $33.89M |
 Odyssey Therapeutics, Inc. | ODTX | 457.84K | $8.57M |